Chemokine ligand 20 enhances progression of hepatocellular carcinoma via epithelial-mesenchymal transition

World Journal of Gastroenterology

Volumn 21, Issue 2, 2015, Pages 475-483

  Hou, Ke Zhu ^a   Fu, Zhi Qiang ^a   Gong, Hua ^a  

^a Shidong Hospital   (China)

Author keywords

Chemokine ligand 20; Epithelialmesenchymal transition; Hepatocellular carcinoma; Phosphoinositide kinase 3 AKT; Prognosis; Wnt catenin

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA FETOPROTEIN; BETA CATENIN; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; UVOMORULIN; VIMENTIN; CCL20 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CHRONIC HEPATITIS; COMPARATIVE STUDY; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; FOLLOW UP; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN VITRO STUDY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; MIDDLE AGED; OVERALL SURVIVAL; PHENOTYPE; PREDICTIVE VALUE; RADICAL RESECTION; SIGNAL TRANSDUCTION; TUMOR DIFFERENTIATION; TUMOR GROWTH; TUMOR INVASION; TUMOR RECURRENCE; TUMOR VOLUME; WESTERN BLOTTING; CARCINOMA, HEPATOCELLULAR; CELL MOTION; CHI SQUARE DISTRIBUTION; DISEASE COURSE; DRUG EFFECTS; KAPLAN MEIER METHOD; LIVER NEOPLASMS; METABOLISM; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; RISK FACTOR; TIME; TREATMENT OUTCOME; TUMOR CELL LINE;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CHEMOKINE CCL20; CHI-SQUARE DISTRIBUTION; DISEASE PROGRESSION; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; PHENOTYPE; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SIGNAL TRANSDUCTION; TIME FACTORS; TREATMENT OUTCOME;

EID: 84920971065     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v21.i2.475     Document Type: Article

References (30)

1. Lau WY, Lai EC. Hepatocellular carcinoma: current management and recent advances. Hepatobiliary Pancreat Dis Int 2008; 7: 237-257 [PMID: 18522878]
2. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003; 362: 1907-1917 [PMID: 14667750 DOI: 10.1016/ SO140-6736(03)14961-1]
3. Shariff MI, Cox IJ, Gomaa AI, Khan SA, Gedroyc W, Taylor-Robinson SD. Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics. Expert Rev Gastroenterol Hepatol 2009; 3: 353-367 [PMID: 19673623 DOI: 10.1586/egh.09.35]
4. Yeh CT, Huang YH, Liang KH, Chang ML, Hsu CW, Chen YC, Chen TC, Yeh TS, Lee WC. Segregation of signaling proteins as prognostic predictors for local recurrence and distant metastasis in hepatocellular carcinoma. Int J Oncol 2014; 44: 491-504 [PMID: 24297625 DOI: 10.3892/ijo.2013.2198]
5. Liu L, Dai Y, Chen J, Zeng T, Li Y, Chen L, Zhu YH, Li J, Li Y, Ma S, Xie D, Yuan YF, Guan XY. Maelstrom promotes hepatocellular carcinoma metastasis by inducing epithelialmesenchymal transition by way of Akt/GSK-3β/Snail signaling. Hepatology 2014; 59: 531-543 [PMID: 23929794 DOI: 10.1002/hep.26677]
6. Okimoto K, Ogasawara S, Chiba T, Kanai F, Yokota H, Motoyama T, Suzuki E, Ooka Y, Tawada A, Iwadate Y, Saeki N, Yokosuka O. Successful resection of intracranial metastasis of hepatocellular carcinoma. Case Rep Gastroenterol 2013; 7: 182-187 [PMID: 23626520 DOI: 10.1159/000350673]
7. Lu T, Seto WK, Zhu RX, Lai CL, Yuen MF. Prevention of hepatocellular carcinoma in chronic viral hepatitis B and C infection. World J Gastroenterol 2013; 19: 8887-8894 [PMID: 24379612 DOI: 10.3748/wjg.v19.i47.8887]
8. Kubo S, Takemura S, Sakata C, Urata Y, Uenishi T. Adjuvant therapy after curative resection for hepatocellular carcinoma associated with hepatitis virus. Liver Cancer 2013; 2: 40-46 [PMID: 24159595 DOI: 10.1159/000346214]
9. Bhala N, Jouness RI, Bugianesi E. Epidemiology and natural history of patients with NAFLD. Curr Pharm Des 2013; 19: 5169-5176 [PMID: 23394091]
10. Loomba R, Yang HI, Su J, Brenner D, Barrett-Connor E, Iloeje U, Chen CJ. Synergism between obesity and alcohol in increasing the risk of hepatocellular carcinoma: a prospective cohort study. Am J Epidemiol 2013; 177: 333-342 [PMID: 23355498 DOI: 10.1093/aje/kws252]
11. Carr BI, Guerra V. HCC and its microenvironment. Hepatogastroenterology 2013; 60: 1433-1437 [PMID: 23933936 DOI: 10.5754/hge121028]
12. Leonardi GC, Candido S, Cervello M, Nicolosi D, Raiti F, Travali S, Spandidos DA, Libra M. The tumor microenvironment in hepatocellular carcinoma (review). Int J Oncol 2012; 40: 1733-1747 [PMID: 22447316 DOI: 10.3892/ijo.2012.1408]
13. Schutyser E, Struyf S, Van Damme J. The CC chemokine CCL20 and its receptor CCR6. Cytokine Growth Factor Rev 2003; 14: 409-426 [PMID: 12948524 DOI: 10.1016/S1359-6101(03)00049-2]
14. Marsigliante S, Vetrugno C, Muscella A. CCL20 induces migration and proliferation on breast epithelial cells. J Cell Physiol 2013; 228: 1873-1883 [PMID: 23460117 DOI: 10.1002/ jcp.24349]
15. Vicinus B, Rubie C, Stegmaier N, Frick VO, Kölsch K, Kauffels A, Ghadjar P, Wagner M, Glanemann M. miR-21 and its target gene CCL20 are both highly overexpressed in the microenvironment of colorectal tumors: significance of their regulation. Oncol Rep 2013; 30: 1285-1292 [PMID: 23817679 DOI: 10.3892/or.2013.2580]
16. Franco-Chuaire ML, Magda Carolina SC, Chuaire-Noack L. Epithelial-mesenchymal transition (EMT): principles and clinical impact in cancer therapy. Invest Clin 2013; 54: 186-205 [PMID: 23947008]
17. Gao D, Vahdat LT, Wong S, Chang JC, Mittal V. Microenvironmental regulation of epithelial-mesenchymal transitions in cancer. Cancer Res 2012; 72: 4883-4889 [PMID: 23002209 DOI: 10.1158/0008-5472]
18. Li W, Gomez E, Zhang Z. Immunohistochemical expression of stromal cell-derived factor-1 (SDF-1) and CXCR4 ligand receptor system in hepatocellular carcinoma. J Exp Clin Cancer Res 2007; 26: 527-533 [PMID: 18365549]
19. Fujii H, Itoh Y, Yamaguchi K, Yamauchi N, Harano Y, Nakajima T, Minami M, Okanoue T. Chemokine CCL20 enhances the growth of HuH7 cells via phosphorylation of p44/42 MAPK in vitro. Biochem Biophys Res Commun 2004; 322: 1052-1058 [PMID: 15336571 DOI: 10.1016/j.bbrc.2004.07.207]
20. Rubie C, Frick VO, Wagner M, Rau B, Weber C, Kruse B, Kempf K, Tilton B, König J, Schilling M. Enhanced expression and clinical significance of CC-chemokine MIP-3 alpha in hepatocellular carcinoma. Scand J Immunol 2006; 63: 468-477 [PMID: 16764701 DOI: 10.1111/j.1365-3083]
21. Zheng K, Li HY, Su XL, Wang XY, Tian T, Li F, Ren GS. Chemokine receptor CXCR7 regulates the invasion, angiogenesis and tumor growth of human hepatocellular carcinoma cells. J Exp Clin Cancer Res 2010; 29: 31 [PMID: 20380740 DOI: 10.1186/1756-9966-29-31]
22. Zhou SL, Dai Z, Zhou ZJ, Wang XY, Yang GH, Wang Z, Huang XW, Fan J, Zhou J. Overexpression of CXCL5 mediates neutrophil infiltration and indicates poor prognosis for hepatocellular carcinoma. Hepatology 2012; 56: 2242-2254 [PMID: 22711685 DOI: 10.1002/hep.25907]
23. Biswas S, Sengupta S, Roy Chowdhury S, Jana S, Mandal G, Mandal PK, Saha N, Malhotra V, Gupta A, Kuprash DV, Bhattacharyya A. CXCL13-CXCR5 co-expression regulates epithelial to mesenchymal transition of breast cancer cells during lymph node metastasis. Breast Cancer Res Treat 2014; 143: 265-276 [PMID: 24337540 DOI: 10.1007/s10549-013-2811-8]
24. Ploenes T, Scholtes B, Krohn A, Burger M, Passlick B, Mller-Quernheim J, Zissel G. CC-chemokine ligand 18 induces epithelial to mesenchymal transition in lung cancer A549 cells and elevates the invasive potential. PLoS One 2013; 8: e53068 [PMID: 23349697 DOI: 10.1371/journal.pone.0053068]
25. Albert S, Hourseau M, Halimi C, Serova M, Descatoire V, Barry B, Couvelard A, Riveiro ME, Tijeras-Raballand A, de Gramont A, Raymond E, Faivre S. Prognostic value of the chemokine receptor CXCR4 and epithelial-to-mesenchymal transition in patients with squamous cell carcinoma of the mobile tongue. Oral Oncol 2012; 48: 1263-1271 [PMID: 22776129 DOI: 10.1016/j.oraloncology.2012.06.010]
26. Li X, Ma Q, Xu Q, Liu H, Lei J, Duan W, Bhat K, Wang F, Wu E, Wang Z. SDF-1/CXCR4 signaling induces pancreatic cancer cell invasion and epithelial-mesenchymal transition in vitro through non-canonical activation of Hedgehog pathway. Cancer Lett 2012; 322: 169-176 [PMID: 22450749 DOI: 10.1016/j.canlet.2012.02.035]
27. Matsushita K, Toiyama Y, Tanaka K, Saigusa S, Hiro J, Uchida K, Inoue Y, Kusunoki M. Soluble CXCL16 in preoperative serum is a novel prognostic marker and predicts recurrence of liver metastases in colorectal cancer patients. Ann Surg Oncol 2012; 19 Suppl 3: S518-S527 [PMID: 21845497 DOI: 10.1245/s10434-011-1993-8]
28. Chang L, Graham PH, Hao J, Ni J, Bucci J, Cozzi PJ, Kearsley JH, Li Y. Acquisition of epithelial-mesenchymal transition and cancer stem cell phenotypes is associated with activation of the PI3K/Akt/mTOR pathway in prostate cancer radioresistance. Cell Death Dis 2013; 4: e875 [PMID: 24157869 DOI: 10.1038/cddis.2013.407]
29. Tsai JH, Hsu LS, Lin CL, Hong HM, Pan MH, Way TD, Chen WJ. 3,5,4-Trimethoxystilbene, a natural methoxylated analog of resveratrol, inhibits breast cancer cell invasiveness by downregulation of PI3K/Akt and Wnt/β-catenin signaling cascades and reversal of epithelial-mesenchymal transition. Toxicol Appl Pharmacol 2013; 272: 746-756 [PMID: 23921149 DOI: 10.1016/j.taap.2013.07.019]
30. Choi JH, Hwang YP, Kim HG, Khanal T, Do MT, Jin SW, Han HJ, Lee HS, Lee YC, Chung YC, Jeong TC, Jeong HG. Saponins from the roots of Platycodon grandiflorum suppresses TGFβ1-induced epithelial-mesenchymal transition via repression of PI3K/Akt, ERK1/2 and Smad2/3 pathway in human lung carcinoma A549 cells. Nutr Cancer 2014; 66: 140-151 [PMID: 24341702 DOI: 10.1080/01635581.2014.853087]